Colonial Trust’s Hologic HOLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-50
| Closed | -$3.78K | – | 1154 |
|
|
2026
Q1 | $3.78K | Sell |
50
-258
| -84% | -$19.4K | ﹤0.01% | 912 |
|
|
2025
Q4 | $22.9K | Sell |
308
-2,300
| -88% | -$168K | ﹤0.01% | 667 |
|
|
2025
Q3 | $176K | Sell |
2,608
-25
| -0.9% | -$1.66K | 0.02% | 333 |
|
|
2025
Q2 | $172K | Hold |
2,633
| – | – | 0.03% | 336 |
|
|
2025
Q1 | $163K | Sell |
2,633
-44
| -2% | -$2.92K | 0.03% | 333 |
|
|
2024
Q4 | $193K | Buy |
2,677
+40
| +2% | +$3.12K | 0.03% | 313 |
|
|
2024
Q3 | $215K | Buy |
2,637
+4
| +0.2% | +$320 | 0.03% | 293 |
|
|
2024
Q2 | $196K | Buy |
2,633
+500
| +23% | +$37.5K | 0.03% | 276 |
|
|
2024
Q1 | $166K | Sell |
2,133
-100
| -4% | -$7.44K | 0.03% | 311 |
|
|
2023
Q4 | $160K | Hold |
2,233
| – | – | 0.03% | 302 |
|
|
2023
Q3 | $155K | Buy |
2,233
+50
| +2% | +$3.78K | 0.04% | 274 |
|
|
2023
Q2 | $177K | Buy |
2,183
+383
| +21% | +$31.3K | 0.04% | 244 |
|
|
2023
Q1 | $145K | Hold |
1,800
| – | – | 0.04% | 276 |
|
|
2022
Q4 | $135K | Buy |
+1,800
| New | +$128K | 0.04% | 266 |
|
Other funds holding HOLX
Colonial Trust's HOLX Position: Q2 2026 in Review
Colonial Trust sold out of Hologic (HOLX) in Q2 2026, closing a stake of 50 shares — an estimated $3.78K sold.
Colonial Trust first reported a position in HOLX in Q4 2022 and held it in 14 quarters. The position peaked at $215K in Q3 2024. 2 funds tracked by Wall St. Rank hold HOLX as of Q2 2026.
- Colonial Trust reported no remaining Hologic position as of Q2 2026 after selling out during the quarter.
- Colonial Trust sold 50 Hologic shares in Q2 2026, an estimated $3.78K.
- Colonial Trust first reported a position in Hologic in Q4 2022 and held it in 14 quarters.
- Colonial Trust's Hologic position peaked at $215K in Q3 2024.
- 2 funds tracked by Wall St. Rank held Hologic as of Q2 2026.
Based on Colonial Trust's 13F filing for Q2 2026, filed 11 Aug 2026.